Humana Inc

HUM is in a Stage 2 advancing regime, driven by an active Parabola continuation pattern and rising short-term EMAs. A recent pullback into the 9/21 EMA zone has shown tentative support, offering a favorable entry aligned with the medium-term bullish structure above the 50DMA, while the long-term downtrend remains an overarching caution. Execute Buy Now on continued acceptance at dynamic EMA support.

• ↑Membership rose 1M (20% YoY), with 70% switchers from rivals
• ↑Upsized 2025 adjusted EPS guidance to ~$17 on cost efficiencies
• ↓Low 0.8% net margin reflects weak profitability factors